The quinoxaline chromophores of the antibiotics produced by Streptomyces triostinicus are derived from tryptophan. Protoplasts of this organism made novel products when they were incubated with DL-5-fluorotryptophan or DL-6-fluorotryptophan. When added to batch cultures of the organism, DL-5-fluorotryptophan, at concentrations as low as 10 p~, inhibited both mycelial growth and triostin production, but gave rise to novel products. These have been characterized, using fast atom bombardment mass spectrometry, as novel triostins in which one or both of the quinoxaline rings contain an atom of fluorine. The chromatographic properties of the triostins arising from the incorporation of DL-5-fluorotryptophan are very similar to those of triostins containing chlorine or bromine at position 6 of the quinoxaline ring; they are clearly different from those having a chlorine atom at position 7. Accordingly, it is suggested that the carbon atom at position 5 of the indole ring of tryptophan ends up at position 6 of the quinoxaline ring system in triostins A and C.
The quinoxaline chromophores of the antibiotics produced by Streptomyces triostinicus are derived from tryptophan. Protoplasts of this organism made novel products when they were incubated with DL-5-fluorotryptophan or DL-6-fluorotryptophan. When added to batch cultures of the organism, DL-5-fluorotryptophan, at concentrations as low as 10 p~, inhibited both mycelial growth and triostin production, but gave rise to novel products. These have been characterized, using fast atom bombardment mass spectrometry, as novel triostins in which one or both of the quinoxaline rings contain an atom of fluorine. The chromatographic properties of the triostins arising from the incorporation of DL-5-fluorotryptophan are very similar to those of triostins containing chlorine or bromine at position 6 of the quinoxaline ring; they are clearly different from those having a chlorine atom at position 7. Accordingly, it is suggested that the carbon atom at position 5 of the indole ring of tryptophan ends up at position 6 of the quinoxaline ring system in triostins A and C.
I N T R O D U C T I O N
Triostin antibiotics are cyclic octadepsipeptides produced by several Streptomyces species (Kuroya et al., 1961; Katagiri, 1972) . They are characterized by the possession of two quinoxaline-2-carboxylic acid chromophores and a disulphide cross-bridge (Otsuka & Shoji, 1965) (Fig. 1 ). There are three naturally-occurring members of the family which differ only in the nature of the branched-chain amino acid residues at two rotationally equivalent positions in the peptide ring (Fig. 1) .
The triostins have potent antitumour and antimicrobial activity (Katagiri et al., 1975 ) which may be attributed to their capacity to bind to the DNA of susceptible cells via a mechanism involving simultaneous intercalation of both chromophores (Waring, 1979) . Using a series of chromophore-substituted derivatives it has been shown that the quinoxaline rings play an important role in determining the antimicrobial activities and DNA-binding properties of these antibiotics (Cornish et al., 1983~) . To date, novel triostins have been prepared by a process of directed biosynthesis which exploits the finding that the producing organisms will incorporate into the antibiotics a variety of heterocyclic acids (Yoshida et al., 1968 (Yoshida et al., , 1970 Katagiri et al., 1975; Cornish et al., 1 9 8 3~) in place of the natural chromophore precursor, which appears to be quinoxaline-2-carboxylic acid (Yoshida et al., 1970) .
As regards the production of triostins by Streptomyces sp. s-2-210L, it has been shown that all the amino acid residues of the peptide ring are derived from the corresponding L-isomers, the Nmethyl groups coming from methionine (Yoshida & Katagiri, 1969) . By means of isotopic labelling studies it has been shown that this organism converts tryptophan to quinoxaline-2-carboxylic acid, probably via L-kynurenine and kynuramine (Yoshida et af., 1970) .
The present study began with an investigation into the origin of the quinoxaline chromophores of the triostins produced by Streptomyces triostinicus; it then turned into a feasibility study to examine whether chromophore-substituted triostins might be produced by supplementing cultures with analogues of tryptophan rather than analogues of quinoxaline-2-carboxylic acid. Protoplasts of S. triostinicus were used as tools to examine the short-term effects of substituted tryptophans on triostin biosynthesis and to screen for incorporation into novel antibiotics. Conventional cultures of mycelia were used to prepare new derivatives in quantities sufficient for characterization by fast atom bombardment mass spectrometry.
METHODS
Chemiculs. Solvents and general reagents were purchased from Fisons, Loughborough, Leicestershire, U K . All derivatives, isomers and analogues of tryptophan were obtained from Sigma. Quinoxaline-2-carboxylic acid was a gift from ICI. Halogenated derivatives of quinoxaline-2-carboxylic acid were obtained from the same sources as previously reported (Cornish et a / . , 1 9 8 3~) .
Triostin A, triostin C and derivatives of triostin A having both quinoxaline chromophores replaced by 7-chloroquinoxaline-2-carboxyl. 6-chloroquinoxaline-2-carboxyl, or 6-bromoquinoxaline-2-carboxyl residues were prepared and characterized as previously described (Cornish et a/., 1983 a) .
Rucliochemiculs. The following T-labelled amino acids were purchased from Amersham : DL-[rnethy/ene-'Tltryptophan, 56-5 mCi mmol-' ; DL-[benzene ring-lTItryptophan, 79 mCi mmol-' ; L-[rnethy/-14C]methionine, 56.7 mCi mmol-' ; L-[U-"C]alanine, 171 mCi mmol-' ; ~-[ U -~T ] v a l i n e , 285 mCi mmol-' ; ~-[U-~T]cysteine, 30.2 mCi mmol-' ; and L-[ U-14C]serine, 170 mCi mmol-I (1 mCi = 37 MBq). These isotopically labelled materials were used at the specific activities supplied unless otherwise stated.
Organism and culture conditions. Streptomyces triostinicus ATCC 21043 (a gift from ICI) was maintained on ISP7 agar (Shirling & Gottlieb, 1966) . Spore suspensions were prepared from two slants and used to inoculate a 2-litre Erlenmeyer flask containing 500 ml of the seed medium described by Yoshida & Katagiri (1967) . Mycelium which had developed after 48 h incubation in this medium provided the inoculum for subsequent experiments. All incubations were done in a New Brunswick G-25 orbital incubator operating at 28 "C and 240 r.p.m.
Preparation ojprotoplasts. The susceptibility of mycelia of S . triostinicus towards lysozyme was found to be critically dependent on the composition of the medium used to support growth. After some experimentation the following medium was devised which yielded satisfactory results: mglucose, 20 g; Bacto-peptone, 10 g; yeast extract, 10 g; NaCl, 3 g; CaC03, 3 g; and deionized water, 1 litre (pH 7.0). Protoplasts were prepared from mycelia grown in 2-litre Erlenmeyer flasks containing 500 ml of this medium. Each flask was inoculated with 20 ml of culture prepared in the seed medium (see above). After 72 h incubation, the mycelium from a single flask was harvested by centrifugation (1OOOg for 15 min), washed once with 500 ml 10% (w/v) sucrose, collected on a tared filter paper using a Buchner funnel and the wet weight determined. The mycelial cake was resuspended in the protoplast buffer of Keller & Kleinkauf (1977) [25 mM-TES; 25 mM-CaC1, ; 10 mM-MgC12 ; 0.3 mM-K2HP04; 0.3 M-sucrose; and mgalactose, 10 g 1-I (pH 7.6)] to a density of I g cells per 5 ml buffer. Solid lysozyme [40000 units (mg protein)-'] was added to the mycelial suspension to a concentration of 2.5 mg ml-I and protoplasts were prepared as follows (based on the method of Cornish et al., 19836). The suspension was incubated in a New Brunswick Aquatherm water bath operating at 28 "C and 100 r.p.m. Release of protoplasts was monitored as described by Keller & Kleinkauf (1977) and found to be complete I35 min after exposure of the mycelium to lysozyme. Residual intact mycelium was removed by passing the incubation mixture through a column (10 x 2.5 cm) containing two plugs of tightly packed glass wool. The filtrate was then centrifuged at 5000g for 25 min at room temperature and the resulting protoplast pellet was resuspended in 3-5 ml of fresh buffer and filtered through two more layers of tightly packed glass wool. The ODbSo of the suspensions was measured at an appropriate dilution in a Unicam SP500 spectrophotometer, and was adjusted by the addition of protoplast buffer to give a value of 8.0. Protoplasts were then used immediately for biosynthetic studies. To check that incorporation of precursors could not be attributed to the persistence of intact mycelia, the level of triostin synthesis (see below) was measured using protoplast suspensions in which the sucrose concentration had been diluted to 0.1 M or less. In these tests the level of incorporation never exceeded 4% of the values obtained with suspensions containing 0.3 Msucrose.
Biosynthrsis yf'triostin byprotoplasts. Incubations were started by adding 0.1 ml volumes of protoplast suspension (OD,,,, = 8.0) to 0.1 ml protoplast buffer containing an appropriate '-'C-labelled precursor of the triostin molecule together with the particular analogue/metabolite of tryptophan under investigation. The quantities of radioactivity used and the concentrations of analogues of tryptophan are given in Results. Protoplast suspensions were shaken in flat-bottomed tubes (10 x 2.5 cm) mounted vertically in a New Brunswick Aquatherm water bath operating at 28 "C and I10 r.p.m. Incubations were stopped after 120 min by the addition of 5 ml ice-cold deionized water. Triostins were extracted into 5 ml ethyl acetate. The organic extracts were taken to dryness, redissolved in chloroform and loaded on to plastic-backed TLC sheets (Merck Kieselgel 60F254, 0.2 mm thickness) which were then developed using ethyl methyl ketone. Radiolabelled products were located using autoradiography. The extent of incorporation of the '-'C-label into triostins was measured using liquid scintillation counting; appropriate regions of the TLC sheets were cut out and immersed for counting silica-side uppermost in 10 ml toluene containing 0.4% (w/v) butyl-PBD. Counting efficiencies with this system lay between 85 and 88%.
Efl2ct.s of'tr.rptophun unulogues on the production of'triostins in batch culture. S. triostinicus was grown in 1 -litre Erlenmeyer flasks containing 500 ml of the maltose minimal medium of Yoshida & Katagiri ( I 969) previously shown to support triostin production by this organism (Katagiri, 1972 ; Cornish rt a/., 1983~). Flasks were inoculated with 13.5 ml volumes of seed culture. Tryptophan analogues, dissolved in a small volume of ethanol, were added into cultures at the time of inoculation. Each day. 10 ml volumes were withdrawn and the mycelium collected on Whatman GFIC filters (2.5 cm diameter) using vacuum filtration. The mycelium was extracted twice using I0 ml volumes of acetone each time, and the residue was then dried and weighed to provide a measure of growth. The levels of triostin in the acetone extracts were determined spectrophotometrically as previously described (Cornish P I ul., 1 9 8 3~) .
HPLC. The antibiotic composition of acetone extracts was examined using HPLC. Extracts were first passed through Millipore FGLD 013 00 filters and then 20 pl volumes were injected on to a Chrompack C I S reversephase column (25 cm). Elution was done at ambient temperature using acetonitrile/water (1 : I , v/v) at a flow rate of 2.0 ml min-I. The effluent was monitored at 243 nm.
Fust utoni honihurtlnirnt niuss sprctronirtry. Antibiotic mixtures as well as pure compounds were analysed by this technique, as described by Santikarn et ul. (1983) . Pirrlfkution of (I i i o i d tliv-iiwrii~c~ of. triostin A ,froni cu1tirre.s suppliwii~ntrd with DL-5-~uorotr!.ptophu~~. Cultures of S . triostiriicus were grown in two 2-litre flasks each containing 1 litre of the maltose minimal medium of Yoshida & Katagiri (1969) . The cultures were supplemented with D~-5-fluorotryptophan (50 p~) at the time of inoculation. The mycelium was harvested for extraction of antibiotics after 9 d incubation as previously described (Cornish et al., 1983~). The major novel triostin was purified using flash column chromatography (Still et al., 1978) followed by preparative TLC as described by Cornish et a/. ( 1 9 8 3~) ; 6 mg of the novel derivative were recovered. Fig. 2 shows radiolabelled products recovered from suspensions of protoplasts incubated with those 'T-labelled amino acids previously reported by Yoshida & Katagiri (1969) amino acid (Yoshida & Katagiri, 1969) , whereas in triostin C these residues are replaced by two moieties of L-N,y-dimethyl-allo-isoleucine (Otsuka & Shoji, 1965) . A minor component was always detected running on chromatograms between triostins A and C. This was probably triostin Bo, a hybrid structure containing one residue of L-N-methylvaline and one of L-N,ydimethyl-allo-isoleucine, which is often produced in small amounts by these organisms (Katagiri, 1972) . Other minor radioactively labelled components (compare also EBect of' quinoxaline-2-carboxylic acid on the labelling of triostins by 4C-labelled tryptophan From the data in Table 2 it can be seen that addition of quinoxaline-2-carboxylic acid markedly reduced the extent of incorporation of DL-[benzene ring-U-14C]tryptophan and DL-[methylene-14C]tryptophan into triostins A and C. As expected a large reduction in the extent of labelling was also observed by adding L-tryptophan (Table 2) while no effect was found with Dtryptophan, even when this was present in incubations at a concentration of 10 mM (results not shown). Addition of quinoxaline-2-carboxylic acid did not reduce the extent of labelling of triostins by ~-[rnethy/-~~C]methionine; indeed it led to a 56% stimulation of incorporation. Evidently quinoxaline-2-carboxylic acid was competing directly with 4C-labelled tryptophan, and not inhibiting antibiotic synthesis in a non-specific fashion.
R E S U L T S

Synthesis of triostins de nouo by protoplasts of S . triostinicus
EJects of' analogues 01' quino?caline-2-carbo.uylic acid and analogues of' tryptophan on the synthesis of' triostins by protoplasts Suspensions of protoplasts behaved in all respects like cultures of S. triostinicus as regards their capacity to make new products in the presence of 6-chloroquinoxaline-2-carboxylic acid (and its methyl ester), 7-chloroquinoxaline-2-carboxylic acid, and 6-bromoquinoxaline-2- Table  I 
. Eficiency of incorporation of 4C-labelled amino acids into triostins by protoplasts
Experiments were done as described in the legend to Fig. 2 . Labelled products were separated using TLC and located using autoradiography. Regions of TLC sheets containing 14C-labelled triostins were cut out and the radioactivity counted. Estimates of error are shown as mean f carboxylic acid (Cornish et af., 1 9 8 3~) (Fig. 3) . Cultures of S . triostinicus incorporate these analogues into novel triostins, giving rise to a mixture of six antibiotics containing triostin A, triostin C (the levels of which are markedly reduced relative to unsupplemented controls) and their respective derivatives in which one or both quinoxaline chromophores are replaced (Cornish et af., 1983~) . All six components may be resolved using HPLC, but complete separation has not proved possible using TLC. From Fig. 3 it can be seen that all four halogenated derivatives of quinoxaline-2-carboxylic acid markedly suppressed synthesis of the natural triostins by protoplasts, and led to the appearance of two or three additional labelled bands in each case. In order of increasing chromatographic mobility, these correspond to the mono-substituted derivative of triostin A, the bis-substituted derivative of triostin A migrating closely with the mono-substituted derivative of triostin C, and the bis-substituted derivative of triostin C. In each experiment the major novel, labelled component comigrated with a standard of the respective bis-substituted derivative of triostin A. It is clear from Fig. 3 that the chromatographic mobilities of triostins having a halogen atom at position 6 of the quinoxaline ring (tracks 2, 3 and 5) are very different from those of derivatives having a substituent at position 7 (track 4). This shows that the quinoxaline rings are important determinants of chromatographic mobility, and that it is possible to distinguish between triostins having halogen atoms at positions 6 or 7 of the ring system on the basis of their relative mobilities. The autoradiograph in Fig. 4 shows products labelled by ~-[rnethyf-'~C]methionine recovered from suspensions of protoplasts which had been incubated with racemic mixtures of 4-, 5-or 6-fluorotryptophan, or 5-, 6-or 7-methyltryptophan. New labelled products were detected only with DL-5-fluorotryptophan and DL-6-fluorotryptophan. The chromatographic mobilities of the new compounds made with DL-5-fluorotryptophan were very similar to those of triostins having a chlorine or bromine atom at position 6 of the quinoxaline ring (compare Figs 3 and 4) . By contrast, the novel products made with DL-6-fluorotryptophan migrated similarly to triostins having a chlorine atom at position 7 of the ring system. These results suggested that S. triostinicus is able to incorporate 5-and 6-fluorinated derivatives of tryptophan into triostins, the fluorine atoms ending up at positions 6 and 7 of the heterocyclic ring system, respectively. Neither of these analogues of tryptophan suppressed production of the natural antibiotics to the extent observed with analogues of quinoxaline-2-carboxylic acid (compare Figs 3 and 4) .
E#ect of DL-5-puorotryptophan on the production of triostins by batch cultures of S . triostinicus
Further experiments were undertaken to investigate whether the novel products were made by mycelia over a longer period of time and to characterize them further. DL-5-fluorotryptophan inhibited growth and antibiotic production at concentrations as low as 10 PM (Fig. 5 ) whereas DL-tryptophan had little or no effect, even at an initial concentration of 1 mM (not shown). Extracts of cultures supplemented with DL-5-fluorotryptophan at concentrations of 10 p~ and 50 p~ were analysed by HPLC and found to contain four components in addition to triostins A and C. When extracts of unsupplemented cultures were examined by means of fast atom bombardment mass spectrometry, abundant molecular ions were detected which corresponded to triostins A and C (mol. wts 1086 and 1142, respectively). Extracts of cultures supplemented with DL-5-fluorotryptophan gave rise to four additional peaks in the mass spectrum at molecular weights expected for the respective mono-and bis-fluorine-substituted derivatives of triostins A and C ( Table 3 ). The major novel component produced by cultures containing 50pM-DL-5-fluorotryptophan was purified as a white powder and found to have a molecular weight of 1 122, which is correct for bis-fluoroquinoxaline triostin A ( Table 3) .
D I S C U S S I O N
The results presented here establish that L-tryptophan is readily incorporated into triostins by S . triostinicus, and that chromophore-substituted antibiotic analogues may be produced by supplementing cultures with derivatives of tryptophan as well as with derivatives of quinoxaline-2-carboxylic acid. Substituted tryptophan compounds have also been used to prepare analogues of pyrrolnitrin (Gorman et al., 1968) and indolmycin (Werner & Demain, 198 l) , although both of these are comparatively small antibiotics which are derived wholly (pyrrolnitrin) or partially (indolmycin) from tryptophan.
Yoshida et al. (1970) proposed that Streptomyces sp. s-2-210L converts tryptophan to quinoxaline carboxylic acid by way of L-kynurenine and kynuramine (Fig. 6a) . Original evidence for the existence of the pathway depicted in Fig. 6 a was obtained from experiments in which mycelial suspensions of Streptomyces sp. s-2-210L were incubated with samples of [ Tltryptophan specifically labelled at known positions in both the indole ring system and the alanyl side-chain. The incorporation of the label into the quinoxaline chromophores of triostin was subsequently determined (Yoshida et af., 1970) . However, the exact fate of individual carbon atoms in the benzene ring of tryptophan was not investigated. Besides examining the feasibility of producing novel triostins from substituted tryptophans, one of the reasons for the present study was to discover whether relatively inexpensive, commercially available analogues of tryptophan could be used to reveal the fate of particular aromatic carbon atoms of tryptophan upon its conversion into the quinoxaline ring system. We have clearly shown that DL-5-fluorotryptophan is incorporated to produce fluorotriostins, but it has not yet proved possible to determine unambiguously the precise location of the fluorine atoms in the quinoxaline ring system of the novel antibiotics. However, comparison of their chromatographic mobilities with those of halogenated derivatives previously characterized (Cornish et al., 1983) suggests that the fluorine atom at position 5 of the tryptophan ring system ends up at position 6 in quinoxaline-2-carboxylic acid, whereas the scheme for the conversion of tryptophan to quinoxaline-2-carboxylic acid advanced by Yoshida et al. (1970) predicts that it should end up at position 7 (Fig. 6a) . A plausible alternative mechanism which is consistent with both the results of previous labelling studies and the findings reported here is given in Fig. 6(b) . In this scheme, both nitrogen atoms of tryptophan would be incorporated into quinoxaline-2-carboxylic acid, the indole giving rise to N( 1) of the quinoxaline ring system and the amino group giving rise to N(4) (Fig. 66) . The origin of the nitrogen atoms in the quinoxaline ring system of triostins has recently been investigated independently using 5N NMR spectroscopy, with results which are entirely consistent with the mechanism depicted in Fig. 6(b) (Reid et al., 1984) . In previous work we reported that derivatives of quinoxaline-2-carboxylic acid which are incorporated into triostins by S . triostinicus may be added into cultures at an initial concentration of 1 mM without affecting the total level of antibiotic production (Cornish et al.,  1983 a) . By contrast, DL-5-fluorotryptophan proved inhibitory at an initial concentration as low as 10 PM. This difference no doubt arises because tryptophan is an intermediate in a number of metabolic pathways essential for growth of the organism, whereas quinoxaline-2-carboxylic acid is an end-product of metabolism needed only for triostin synthesis. Incorporation of analogues of quinoxaline-2-carboxylic acid into triostins surely results from the broad substrate specificity of the enzyme(s) responsible for attaching the chromophores to the peptide ring. Accordingly, the failure to observe incorporation of methyltryptophan into triostins probably reflects the more restricted substrate specificity of enzymes involved in the conversion of tryptophan to quinoxaline-2-carboxylic acid. Probably this will ultimately limit the range and number of novel triostins which can be produced from substituted derivatives of tryptophan. 
